Drugmakers Duped Medicaid Rebate Regulators, 3rd Circ. Told
A pharmaceutical executive urged the Third Circuit on Wednesday to revive his suit alleging Allergan Inc. and other companies shorted the federal government on drug rebate payments, arguing that the drugmakers...To view the full article, register now.
Already a subscriber? Click here to view full article